Karen Beemon wins the 2007 Retrovirology Prize

December 10, 2007

It was announced today that Dr Karen Beemon has been awarded the third annual Retrovirology Prize. Dr Beemon will receive a $3000 cheque and a crystal trophy and is interviewed in an article published today in the open access journal Retrovirology. She is Professor and Chair of the Biology Department, Johns Hopkins University.

"I am very honored to receive the 2007 Retrovirology Prize. It is wonderful to be recognized by the Retrovirology community. It is gratifying that this prize was awarded for basic research with chicken retroviruses. I became fascinated with these viruses as a graduate student and have studied them ever since. I am amazed at how complex and elegant the simple retroviruses actually are and how much they have taught us about viral gene expression and mechanisms of oncogenesis. I am indebted to my mentors, students, and collaborators, who contributed to this research."

The Retrovirology Prize, awarded annually, recognises an outstanding mid-career retrovirologist aged 45 to 60. The prize, supported by the Ming K. Jeang Foundation, alternates between HIV and non-HIV research. Last year's winner was Dr Joe Sodroski, Professor of Pathology at the Dana-Farber Cancer Institute, Harvard Medical School and Professor of Immunology and Infectious Diseases at Harvard School of Public Health.

The M Jeang Retrovirology Prize winner is selected, by Retrovirology's Editors, from nominations submitted by the journal's Editorial Board. Representing the Editors of Retrovirology, Kuan-Teh Jeang explained why they awarded Dr Beemon with the Retrovirology prize. "Professor Beemon has made tremendous contributions to our understanding of how retroviruses transform cells. She was instrumental in establishing that one of the important transformation mechanisms is the aberrant phosphorylation of cellular proteins on tyrosine residues."

Dr Beemon received her PhD in 1974 from the University of California. She was a postdoctoral fellow there and also at the Salk institute. She was among the first to develop and apply molecular techniques to characterise the genomes of RNA viruses, describe recombination between viral genomes, characterise sarcoma-specific sequences, and perform structure-function analysis of src proteins. Of particular importance, was her discovery that transformation mechanisms of multiple classes of retroviruses involve aberrant phosphorylation of cellular proteins at tyrosine residues. Over the last two decades, Dr. Beemon has contributed significantly to the scientific community's understanding of the role of cis-acting regulatory elements in regulation of RNA splicing, polyadenylation, nuclear export and nonsense-mediated RNA decay.

Dr. Beemon's honors in research recognition include the Faculty Research Award from the American Cancer Society and the Fogarty Senior International Fellowship. She has published nearly 80 peer-reviewed manuscripts and review articles in journals ranked in the top of their subject field (e.g. Cell, PNAS, Journal of Virology, Molecular Cellular Biology, Oncogene, RNA). This year she was appointed a senior editor of the Journal of Virology.
-end-
Notes to Editors

  1. The article featuring an interview with Dr Beemon can be found at the journal website: http://www.retrovirology.com/
  2. Retrovirology is an open access, online journal published by BioMed Central. The journal publishes stringently peer-reviewed, high-impact articles on basic retrovirus research. For more information prize please read the editorial: http://www.retrovirology.com/content/4/1/64
  3. BioMed Central (www.biomedcentral) is an independent online publishing house committed to providing immediate access without charge to the peer-reviewed biological and medical research it publishes. This commitment is based on the view that open access to research is essential to the rapid and efficient communication of science.


BioMed Central

Related RNA Articles from Brightsurf:

A new RNA catalyst from the lab
On the track of evolution: a catalytically active RNA molecule that specifically attaches methyl groups to other RNAs - a research group from the University of Würzburg reports on this new discovery in Nature.

Small RNA as a central player in infections
The most important pathogenicity factors of the gastric pathogen Helicobacter pylori are centrally regulated by a small RNA molecule, NikS.

RNA as a future cure for hereditary diseases
ETH Zurich scientists have developed an RNA molecule that can be used in bone marrow cells to correct genetic errors that affect protein production.

Bringing RNA into genomics
By studying RNA-binding proteins, a research consortium known as ENCODE (Encyclopedia of DNA Elements) has identified genomic sites that appear to code for RNA molecules that influence gene expression.

RNA key in helping stem cells know what to become
If every cell has the same genetic blueprint, why does an eye cell look and act so differently than a brain cell or skin cell?

RNA structures by the thousands
Researchers from Bochum and Münster have developed a new method to determine the structures of all RNA molecules in a bacterial cell at once.

New kind of CRISPR technology to target RNA, including RNA viruses like coronavirus
Researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center and New York University have developed a new kind of CRISPR screen technology to target RNA.

Discovery of entirely new class of RNA caps in bacteria
The group of Dr. Hana Cahová of the Institute of Organic Chemistry and Biochemistry of the CAS, in collaboration with scientists from the Institute of Microbiology of the CAS, has discovered an entirely new class of dinucleoside polyphosphate 5'RNA caps in bacteria and described the function of alarmones and their mechanism of function.

New RNA mapping technique shows how RNA interacts with chromatin in the genome
A group led by scientists from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a new method, RADICL-seq, which allows scientists to better understand how RNA interacts with the genome through chromatin--the structure in which the genome is organized.

Characterising RNA alterations in cancer
The largest and most comprehensive catalogue of cancer-specific RNA alterations reveals new insights into the cancer genome.

Read More: RNA News and RNA Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.